These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22818215)
1. Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study. Johnson MJ; Sheard L; Maraveyas A; Noble S; Prout H; Watt I; Dowding D BMC Med Inform Decis Mak; 2012 Jul; 12():75. PubMed ID: 22818215 [TBL] [Abstract][Full Text] [Related]
2. The ethical decisions UK doctors make regarding advanced cancer patients at the end of life--the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study. Sheard L; Prout H; Dowding D; Noble S; Watt I; Maraveyas A; Johnson M BMC Med Ethics; 2012 Sep; 13():22. PubMed ID: 22947200 [TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280 [TBL] [Abstract][Full Text] [Related]
4. Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study. Sheard L; Prout H; Dowding D; Noble S; Watt I; Maraveyas A; Johnson M Palliat Med; 2013 Apr; 27(4):339-48. PubMed ID: 23093572 [TBL] [Abstract][Full Text] [Related]
5. How do palliative physicians manage venous thromboembolism? Johnson MJ; Sherry K Palliat Med; 1997 Nov; 11(6):462-8. PubMed ID: 9519169 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410 [TBL] [Abstract][Full Text] [Related]
8. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice. den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552 [TBL] [Abstract][Full Text] [Related]
9. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center. Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142 [TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom. Vermaak PV; D'Asta F; Provins J; Farr M; Wilson YT Burns; 2019 Sep; 45(6):1379-1385. PubMed ID: 31079961 [TBL] [Abstract][Full Text] [Related]
12. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis. Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386 [TBL] [Abstract][Full Text] [Related]
13. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin. Hyers TM; Spyropoulos AC; J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932 [TBL] [Abstract][Full Text] [Related]
14. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M; Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Robertson L; Strachan J Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640 [TBL] [Abstract][Full Text] [Related]
16. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Noble SI; Shelley MD; Coles B; Williams SM; Wilcock A; Johnson MJ; Lancet Oncol; 2008 Jun; 9(6):577-84. PubMed ID: 18510989 [TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient). Pernod G; Joly M; Sonnet B J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939 [TBL] [Abstract][Full Text] [Related]
18. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy. van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187 [TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Geerts WH; Bergqvist D; Pineo GF; Heit JA; Samama CM; Lassen MR; Colwell CW Chest; 2008 Jun; 133(6 Suppl):381S-453S. PubMed ID: 18574271 [TBL] [Abstract][Full Text] [Related]
20. Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants. Uppuluri EM; Burke KR; Haaf CM; Shapiro NL J Oncol Pharm Pract; 2019 Mar; 25(2):261-268. PubMed ID: 28942721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]